Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by StevenBirchon Mar 31, 2021 5:30pm
208 Views
Post# 32919369

RE:RE:RE:RE:RE:RE:Warrants

RE:RE:RE:RE:RE:RE:WarrantsYes they would. People get caught up in stock vs warrants or exercising warrants vs selling them but it's all just math. If as you say the stock had a price of $44 and the warrants would have an intrinsic value of $5.41 then in theory that is what they would trade at. Now at any moment in time the bid could be lower because of liquidity and the market for the warrants just being thinner but that doesn't change the value.

Gaps do occur in situations like this but there are people who specifically look for those opportunities, it's free money so to speak. In the old days they had arbitrage desks who looked for these types of gaps that occurred in interlisted stocks, Toronto & any foreign market, because of fast moving markets and currency changes. They get filled quickly and everything returns to it's real value - market wise that is.

At worst I could see a small discount but not nearly enough to worry about because when push comes to shove the warrants can always be exercised, if not by the warrant holder who maybe doesn't have the cash sitting around then by the many deep pocketed people here who would love to add another risk free amount to their profits.

I always thought the best approach was to have some of each then there are no worries.


HollywoodHuss wrote: My question for warrants was will price go up in relation to potential buy out price. Say it's the 2B buyout at $44 a share. With the calculation of that if the stock went to $44. The warrants would then be priced at $5.41 CAD? Would these prices be reflective in the market on the exchange?


<< Previous
Bullboard Posts
Next >>